Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
73.05
-0.94 (-1.27%)
Apr 29, 2026, 9:38 AM EDT - Market open
Oruka Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 3,667 | 1,467 | 679 |
| Market Cap Growth | 1175.25% | 116.22% | - |
| Enterprise Value | 3,236 | 971 | 325 |
| Last Close Price | 73.99 | 30.31 | 19.39 |
| PB Ratio | 7.69 | 3.11 | 1.78 |
| P/TBV Ratio | 7.92 | 3.13 | 1.79 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.03 |
| Net Debt / EBITDA Ratio | 3.92 | 3.92 | 4.12 |
| Net Debt / FCF Ratio | 5.40 | 5.40 | 6.20 |
| Quick Ratio | 21.92 | 21.92 | 28.80 |
| Current Ratio | 22.37 | 22.37 | 28.89 |
| Return on Equity (ROE) | -24.69% | -24.69% | - |
| Return on Assets (ROA) | -17.25% | -17.25% | - |
| Return on Capital Employed (ROCE) | -25.80% | -25.80% | -24.90% |
| Earnings Yield | -2.27% | -7.19% | -13.46% |
| FCF Yield | -2.38% | -6.03% | -9.33% |
| Buyback Yield / Dilution | -171.69% | -171.69% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.